We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Jefferson Health & Sarah Cannon Research Institute Announce Cancer Drug Development Collaboration

News   Jun 04, 2018 | Original story from Sarah Cannon

 
Jefferson Health & Sarah Cannon Research Institute Announce Cancer Drug Development Collaboration

Credit: Sarah Cannon

 
 
 

RELATED ARTICLES

Loss of Tight Junction Protein Promotes Development of Precancerous Cells

News

Tight junctions are multi-protein complexes that serve as barriers in epithelial tissues such as the skin or lining of the gut. Loss of a specific tight junction barrier protein, claudin 18, occurs in the majority of gastric cancer patients and is correlated with poor prognosis in patients with advanced gastric cancer.

READ MORE

Excess Body Weight Responsible for 4% of Cancers Worldwide

News

Policies, economic systems, and marketing practices that promote the consumption of energy-dense, nutrient-poor food, changing behavioral patterns that couple high total energy intake with insufficient physical activity, and human-built environments that amplify these factors are driving a worldwide rise in excess body weight, according to a new report.

READ MORE

Drug Cocktail Cripples Cancer Cells

News

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE